Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of ...

Most people have the Epstein-Barr (EBV) virus. Sometimes people are unaware of this virus in their body; it settles into immune cells and remains for the duration.

Scientists have taken a significant step toward neutralizing Epstein-Barr virus. Scientists at Fred Hutch Cancer Center have reported an important advance in the effort to stop Epstein Barr virus (EBV ...

Monoclonal antibodies (mAbs) are highly specific, laboratory-produced antibodies designed to target a single specific epitope or binding site on an antigen. Unlike polyclonal antibodies, which are a ...

Could monoclonal antibodies be the key to tackling the growing problem of antimicrobial resistance? A team led by researchers at the University of Cambridge has developed a monoclonal antibody drug ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

Monoclonal antibodies offer key opportunities in precision immunotherapy for cancer and chronic diseases. Focus areas include targeted novel therapies, stereo-specific antibodies for enhanced efficacy ...

Monoclonal antibodies (mAbs) have been a key therapeutic option for non-communicable diseases for decades, and a small number of mAbs have helped treat infectious diseases, including COVID-19. The ...

Zenyaku Kogyo obtains Japanese approval for anti-CD20 monoclonal antibody, Rituxan to treat autoimmune haemolytic anaemia: Tokyo Friday, February 20, 2026, 13:00 Hrs [IST] Zenyaku ...

I n 2024, the U.S. Food and Drug Administration (FDA) approved the first monoclonal antibody for reducing food allergy reactions, including anaphylaxis, in adults and children age 1 year or older. The ...

A promising new drug could prevent and even reverse the onset of type 1 diabetes. The experimental monoclonal antibody drug was found to act like a shield to protect insulin-producing cells from ...